Britain’s GlaxoSmithKline (GSK.L) has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland’s Novartis (NOVN.VX), which will see the two pharmaceutical group trade more than $20 billion of assets.
{iframe}http://www.reuters.com/article/2014/11/24/us-gsk-novartis-idUSKCN0J80JR20141124{/iframe}